{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T18:46:27Z","timestamp":1768934787807,"version":"3.49.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,17]],"date-time":"2017-12-17T00:00:00Z","timestamp":1513468800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Valeant Pharmaceuticals (Canada)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00213-017-4811-6","type":"journal-article","created":{"date-parts":[[2017,12,17]],"date-time":"2017-12-17T06:35:58Z","timestamp":1513492558000},"page":"409-417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A prospective observational study of problematic oral cannabinoid use"],"prefix":"10.1007","volume":"235","author":[{"given":"Mark A.","family":"Ware","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc O.","family":"Martel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Jovey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,17]]},"reference":[{"issue":"7","key":"4811_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1212\/01.wnl.0000253187.66183.9c","volume":"68","author":"DI Abrams","year":"2007","unstructured":"Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, Kelly ME, Rowbotham MC, Petersen KL (2007) Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology 68(7):515\u2013521. https:\/\/doi.org\/10.1212\/01.wnl.0000253187.66183.9c","journal-title":"Neurology"},{"issue":"2","key":"4811_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/AJP.0b013e31824c5e4c","volume":"29","author":"SK Aggarwal","year":"2013","unstructured":"Aggarwal SK (2013) Cannabinergic pain medicine: a concise clinical primer and survey of randomized-controlled trial results. Clin J Pain 29(2):162\u2013171. https:\/\/doi.org\/10.1097\/AJP.0b013e31824c5e4c","journal-title":"Clin J Pain"},{"issue":"3","key":"4811_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.pain.2007.03.028","volume":"129","author":"JC Ballantyne","year":"2007","unstructured":"Ballantyne JC, LaForge KS (2007) Opioid dependence and addiction during opioid treatment of chronic pain. Pain 129(3):235\u2013255. https:\/\/doi.org\/10.1016\/j.pain.2007.03.028","journal-title":"Pain"},{"issue":"10","key":"4811_CR4","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1111\/j.1360-0443.2010.03052.x","volume":"105","author":"JA Boscarino","year":"2010","unstructured":"Boscarino JA, Rukstalis M, Hoffman SN, Han JJ, Erlich PM, Gerhard GS, Stewart WF (2010) Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction 105(10):1776\u20131782. https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03052.x","journal-title":"Addiction"},{"issue":"1","key":"4811_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.pain.2007.01.014","volume":"130","author":"SF Butler","year":"2007","unstructured":"Butler SF, Budman SH, Fernandez KC, Houle B, Benoit C, Katz N, Jamison RN (2007) Development and validation of the Current Opioid Misuse Measure. Pain 130(1):144\u2013156. https:\/\/doi.org\/10.1016\/j.pain.2007.01.014","journal-title":"Pain"},{"issue":"9","key":"4811_CR6","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1097\/AJP.0b013e3181f195ba","volume":"26","author":"SF Butler","year":"2010","unstructured":"Butler SF, Budman SH, Fanciullo GJ, Jamison RN (2010) Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy. Clin J Pain 26(9):770\u2013776. https:\/\/doi.org\/10.1097\/AJP.0b013e3181f195ba","journal-title":"Clin J Pain"},{"key":"4811_CR7","doi-asserted-by":"publisher","unstructured":"Carliner H, Brown QL, Sarvet AL, Hasin DS (2017) Cannabis use, attitudes, and legal status in the U.S.: a review. Prev Med. https:\/\/doi.org\/10.1016\/j.ypmed.2017.07.008","DOI":"10.1016\/j.ypmed.2017.07.008"},{"issue":"2","key":"4811_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/00002508-199706000-00009","volume":"13","author":"C Chabal","year":"1997","unstructured":"Chabal C, Erjavec MK, Jacobson L, Mariano A, Chaney E (1997) Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin J Pain 13(2):150\u2013155. https:\/\/doi.org\/10.1097\/00002508-199706000-00009","journal-title":"Clin J Pain"},{"issue":"2","key":"4811_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","volume":"10","author":"R Chou","year":"2009","unstructured":"Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C (2009) Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 10(2):113\u2013130. https:\/\/doi.org\/10.1016\/j.jpain.2008.10.008","journal-title":"J Pain"},{"issue":"3","key":"4811_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1468-1331.2006.01639.x","volume":"14","author":"C Collin","year":"2007","unstructured":"Collin C, Davies P, Mutiboko IK, Ratcliffe S (2007) Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. Eur J Neurol 14(3):290\u2013296. https:\/\/doi.org\/10.1111\/j.1468-1331.2006.01639.x","journal-title":"Eur J Neurol"},{"issue":"5","key":"4811_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1179\/016164109X12590518685660","volume":"32","author":"C Collin","year":"2010","unstructured":"Collin C, Ehler E, Waberzinek G, Alsindi Z, Davies P, Powell K, Notcutt W, O\u2019Leary C, Ratcliffe S, Novakova I, Zapletalova O, Pikova J, Ambler Z (2010) A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis. Neurol Res 32(5):451\u2013459. https:\/\/doi.org\/10.1179\/016164109X12590518685660","journal-title":"Neurol Res"},{"issue":"17","key":"4811_CR12","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.291.17.2114","volume":"291","author":"WM Compton","year":"2004","unstructured":"Compton WM, Grant BF, Colliver JD, Glantz MD, Stinson FS (2004) Prevalence of marijuana use disorders in the United States: 1991\u20131992 and 2001\u20132002. JAMA 291(17):2114\u20132121. https:\/\/doi.org\/10.1001\/jama.291.17.2114","journal-title":"JAMA"},{"issue":"2","key":"4811_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/jama.2016.18900","volume":"317","author":"WM Compton","year":"2017","unstructured":"Compton WM, Han B, Hughes A, Jones CM, Blanco C (2017) Use of marijuana for medical purposes among adults in the United States. JAMA 317(2):209\u2013211. https:\/\/doi.org\/10.1001\/jama.2016.18900","journal-title":"JAMA"},{"key":"4811_CR14","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2147\/JPR.S134330","volume":"10","author":"JM Corroon Jr","year":"2017","unstructured":"Corroon JM Jr, Mischley LK, Sexton M (2017) Cannabis as a substitute for prescription drugs\u2014a cross-sectional study. J Pain Res 10:989\u2013998. https:\/\/doi.org\/10.2147\/JPR.S134330","journal-title":"J Pain Res"},{"issue":"3","key":"4811_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.pain.2007.02.014","volume":"129","author":"MJ Edlund","year":"2007","unstructured":"Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M (2007) Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 129(3):355\u2013362. https:\/\/doi.org\/10.1016\/j.pain.2007.02.014","journal-title":"Pain"},{"issue":"8","key":"4811_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/AJP.0b013e318270fa77","volume":"29","author":"MJ Edlund","year":"2013","unstructured":"Edlund MJ, Sullivan MD, Han X, Booth BM (2013) Days with pain and substance use disorders: is there an association? Clin J Pain 29(8):689\u2013695. https:\/\/doi.org\/10.1097\/AJP.0b013e318270fa77","journal-title":"Clin J Pain"},{"issue":"9","key":"4811_CR17","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1503\/cmaj.100187","volume":"182","author":"AD Furlan","year":"2010","unstructured":"Furlan AD, Reardon R, Weppler C (2010) Opioids for chronic noncancer pain: a new Canadian practice guideline. CMAJ 182(9):923\u2013930. https:\/\/doi.org\/10.1503\/cmaj.100187","journal-title":"CMAJ"},{"issue":"1","key":"4811_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s10865-015-9675-9","volume":"39","author":"EL Garland","year":"2016","unstructured":"Garland EL, Brown SM, Howard MO (2016) Thought suppression as a mediator of the association between depressed mood and prescription opioid craving among chronic pain patients. J Behav Med 39(1):128\u2013138. https:\/\/doi.org\/10.1007\/s10865-015-9675-9","journal-title":"J Behav Med"},{"issue":"4","key":"4811_CR19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1370\/afm.1371","volume":"10","author":"A Grattan","year":"2012","unstructured":"Grattan A, Sullivan MD, Saunders KW, Campbell CI, Von Korff MR (2012) Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Ann Fam Med 10(4):304\u2013311. https:\/\/doi.org\/10.1370\/afm.1371","journal-title":"Ann Fam Med"},{"key":"4811_CR20","unstructured":"Guy W (1976) Assessment manual for psychopharmacology\u2014revised. Department of Health, Education, and Welfare Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, Rockville, MD, pp 218\u2013222"},{"issue":"1","key":"4811_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00213-005-2242-2","volume":"181","author":"M Haney","year":"2005","unstructured":"Haney M, Rabkin J, Gunderson E, Foltin RW (2005) Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology 181(1):170\u2013178. https:\/\/doi.org\/10.1007\/s00213-005-2242-2","journal-title":"Psychopharmacology"},{"issue":"5","key":"4811_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/QAI.0b013e31811ed205","volume":"45","author":"M Haney","year":"2007","unstructured":"Haney M, Gunderson EW, Rabkin J, Hart CL, Vosburg SK, Comer SD, Foltin RW (2007) Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep. J Acquir Immune Defic Syndr (1999) 45(5):545\u2013554. https:\/\/doi.org\/10.1097\/QAI.0b013e31811ed205","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"key":"4811_CR23","doi-asserted-by":"crossref","unstructured":"Hasin DS (2017) US Epidemiology of Cannabis Use and Associated Problems. Neuropsychopharmacology 43(1):195-212","DOI":"10.1038\/npp.2017.198"},{"issue":"12","key":"4811_CR24","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1001\/jamapsychiatry.2015.1858","volume":"72","author":"DS Hasin","year":"2015","unstructured":"Hasin DS, Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, Jung J, Pickering RP, Ruan WJ, Smith SM, Huang B, Grant BF (2015) Prevalence of marijuana use disorders in the United States between 2001\u20132002 and 2012\u20132013. JAMA Psychiatry 72(12):1235\u20131242. https:\/\/doi.org\/10.1001\/jamapsychiatry.2015.1858","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"4811_CR25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1176\/appi.ajp.2015.15070907","volume":"173","author":"DS Hasin","year":"2016","unstructured":"Hasin DS, Kerridge BT, Saha TD, Huang B, Pickering R, Smith SM, Jung J, Zhang H, Grant BF (2016) Prevalence and correlates of DSM-5 cannabis use disorder, 2012-2013: findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Am J Psychiatry 173(6):588\u2013599. https:\/\/doi.org\/10.1176\/appi.ajp.2015.15070907","journal-title":"Am J Psychiatry"},{"issue":"1","key":"4811_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jmpt.2003.11.003","volume":"27","author":"H Hurst","year":"2004","unstructured":"Hurst H, Bolton J (2004) Assessing the clinical significance of change scores recorded on subjective outcome measures. J Manip Physiol Ther 27(1):26\u201335. https:\/\/doi.org\/10.1016\/j.jmpt.2003.11.003","journal-title":"J Manip Physiol Ther"},{"issue":"1","key":"4811_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1472-6963-6-46","volume":"6","author":"TJ Ives","year":"2006","unstructured":"Ives TJ, Chelminski PR, Hammett-Stabler CA, Malone RM, Perhac JS, Potisek NM, Shilliday BB, DeWalt DA, Pignone MP (2006) Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res 6(1):46. https:\/\/doi.org\/10.1186\/1472-6963-6-46","journal-title":"BMC Health Serv Res"},{"key":"4811_CR28","first-page":"941808","volume":"2011","author":"RN Jamison","year":"2011","unstructured":"Jamison RN, Serraillier J, Michna E (2011) Assessment and treatment of abuse risk in opioid prescribing for chronic pain. Pain Res Treat 2011:941808","journal-title":"Pain Res Treat"},{"issue":"2","key":"4811_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","volume":"39","author":"JR Johnson","year":"2010","unstructured":"Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT (2010) Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manag 39(2):167\u2013179. https:\/\/doi.org\/10.1016\/j.jpainsymman.2009.06.008","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"4811_CR30","first-page":"22","volume":"53","author":"M Kahan","year":"2007","unstructured":"Kahan M, Srivastava A (2007) Is there a role for marijuana in medical practice? No. Can Fam Physician Medecin de famille canadien 53(1):22\u201325","journal-title":"Can Fam Physician Medecin de famille canadien"},{"issue":"5","key":"4811_CR31","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.pnpbp.2004.05.027","volume":"28","author":"H Kalant","year":"2004","unstructured":"Kalant H (2004) Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuro-Psychopharmacol Biol Psychiatry 28(5):849\u2013863. https:\/\/doi.org\/10.1016\/j.pnpbp.2004.05.027","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"3","key":"4811_CR32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S1478951507000387","volume":"5","author":"KL Kirsh","year":"2007","unstructured":"Kirsh KL, Jass C, Bennett DS, Hagen JE, Passik SD (2007) Initial development of a survey tool to detect issues of chemical coping in chronic pain patients. Palliat Support Care 5(3):219\u2013226","journal-title":"Palliat Support Care"},{"issue":"5","key":"4811_CR33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0022-3999(97)00171-2","volume":"43","author":"K Kouyanou","year":"1997","unstructured":"Kouyanou K, Pither CE, Wessely S (1997) Medication misuse, abuse and dependence in chronic pain patients. J Psychosom Res 43(5):497\u2013504. https:\/\/doi.org\/10.1016\/S0022-3999(97)00171-2","journal-title":"J Psychosom Res"},{"issue":"11","key":"4811_CR34","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jpain.2009.10.012","volume":"11","author":"JM Liebschutz","year":"2010","unstructured":"Liebschutz JM, Saitz R, Weiss RD, Averbuch T, Schwartz S, Meltzer EC, Claggett-Borne E, Cabral H, Samet JH (2010) Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. J Pain 11(11):1047\u20131055. https:\/\/doi.org\/10.1016\/j.jpain.2009.10.012","journal-title":"J Pain"},{"issue":"1","key":"4811_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jpain.2013.09.014","volume":"15","author":"MO Martel","year":"2014","unstructured":"Martel MO, Dolman AJ, Edwards RR, Jamison RN, Wasan AD (2014) The association between negative affect and prescription opioid misuse in patients with chronic pain: the mediating role of opioid craving. J Pain 15(1):90\u2013100. https:\/\/doi.org\/10.1016\/j.jpain.2013.09.014","journal-title":"J Pain"},{"key":"4811_CR36","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.drugalcdep.2016.02.047","volume":"162","author":"MO Martel","year":"2016","unstructured":"Martel MO, Finan PH, McHugh RK, Issa M, Edwards RR, Jamison RN, Wasan AD (2016) Day-to-day pain symptoms are only weakly associated with opioid craving among patients with chronic pain prescribed opioid therapy. Drug Alcohol Depend 162:130\u2013136. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.02.047","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"4811_CR37","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jpainsymman.2004.04.007","volume":"28","author":"E Michna","year":"2004","unstructured":"Michna E, Ross EL, Hynes WL, Nedeljkovic SS, Soumekh S, Janfaza D, Palombi D, Jamison RN (2004) Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manag 28(3):250\u2013258. https:\/\/doi.org\/10.1016\/j.jpainsymman.2004.04.007","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"4811_CR38","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jpain.2007.10.018","volume":"9","author":"S Narang","year":"2008","unstructured":"Narang S, Gibson D, Wasan AD, Ross EL, Michna E, Nedeljkovic SS, Jamison RN (2008) Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. J Pain 9(3):254\u2013264. https:\/\/doi.org\/10.1016\/j.jpain.2007.10.018","journal-title":"J Pain"},{"issue":"2","key":"4811_CR39","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/pme.12594","volume":"16","author":"S Nielsen","year":"2015","unstructured":"Nielsen S, Lintzeris N, Bruno R, Campbell G, Larance B, Hall W, Hoban B, Cohen ML, Degenhardt L (2015) Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization. Pain Med (Malden, Mass) 16(2):356\u2013366. https:\/\/doi.org\/10.1111\/pme.12594","journal-title":"Pain Med (Malden, Mass)"},{"issue":"2","key":"4811_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/1352458511419700","volume":"18","author":"W Notcutt","year":"2012","unstructured":"Notcutt W, Langford R, Davies P, Ratcliffe S, Potts R (2012) A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex(R) (nabiximols). Mult Scler (Houndmills, Basingstoke, England) 18(2):219\u2013228. https:\/\/doi.org\/10.1177\/1352458511419700","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"5","key":"4811_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/02791072.2015.1096433","volume":"47","author":"LA Osborn","year":"2015","unstructured":"Osborn LA, Lauritsen KJ, Cross N, Davis AK, Rosenberg H, Bonadio F, Lang B (2015) Self-medication of somatic and psychiatric conditions using botanical marijuana. J Psychoactive Drugs 47(5):345\u2013350. https:\/\/doi.org\/10.1080\/02791072.2015.1096433","journal-title":"J Psychoactive Drugs"},{"issue":"Suppl 2","key":"4811_CR42","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1111\/j.1526-4637.2011.01130.x","volume":"12","author":"SD Passik","year":"2011","unstructured":"Passik SD, Lowery A (2011) Psychological variables potentially implicated in opioid-related mortality as observed in clinical practice. Pain Med (Malden, Mass) 12(Suppl 2):S36\u2013S42. https:\/\/doi.org\/10.1111\/j.1526-4637.2011.01130.x","journal-title":"Pain Med (Malden, Mass)"},{"issue":"5","key":"4811_CR43","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jpain.2012.01.003","volume":"13","author":"RK Portenoy","year":"2012","unstructured":"Portenoy RK, Ganae-Motan ED, Allende S, Yanagihara R, Shaiova L, Weinstein S, McQuade R, Wright S, Fallon MT (2012) Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain 13(5):438\u2013449. https:\/\/doi.org\/10.1016\/j.jpain.2012.01.003","journal-title":"J Pain"},{"issue":"3","key":"4811_CR44","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jpain.2011.11.004","volume":"13","author":"KW Saunders","year":"2012","unstructured":"Saunders KW, Von Korff M, Campbell CI, Banta-Green CJ, Sullivan MD, Merrill JO, Weisner C (2012) Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J Pain 13(3):266\u2013275. https:\/\/doi.org\/10.1016\/j.jpain.2011.11.004","journal-title":"J Pain"},{"key":"4811_CR45","doi-asserted-by":"crossref","unstructured":"Savage SR (2008) The language of pain and addiction. In: Smith HS, Passik SD (eds) Pain and chemical dependency. Oxford, pp 9\u201313","DOI":"10.1093\/oso\/9780195300550.003.0002"},{"issue":"6","key":"4811_CR46","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jpain.2016.02.007","volume":"17","author":"SR Savage","year":"2016","unstructured":"Savage SR, Romero-Sandoval A, Schatman M, Wallace M, Fanciullo G, McCarberg B, Ware M (2016) Cannabis in pain treatment: clinical and research considerations. J Pain 17(6):654\u2013668. https:\/\/doi.org\/10.1016\/j.jpain.2016.02.007","journal-title":"J Pain"},{"issue":"9","key":"4811_CR47","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jpain.2005.04.004","volume":"6","author":"BM Schieffer","year":"2005","unstructured":"Schieffer BM, Pham Q, Labus J, Baria A, Van Vort W, Davis P, Davis F, Naliboff BD (2005) Pain medication beliefs and medication misuse in chronic pain. J Pain 6(9):620\u2013629. https:\/\/doi.org\/10.1016\/j.jpain.2005.04.004","journal-title":"J Pain"},{"issue":"4","key":"4811_CR48","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0306-4603(82)90005-3","volume":"7","author":"HA Skinner","year":"1982","unstructured":"Skinner HA (1982) The drug abuse screening test. Addict Behav 7(4):363\u2013371. https:\/\/doi.org\/10.1016\/0306-4603(82)90005-3","journal-title":"Addict Behav"},{"key":"4811_CR49","doi-asserted-by":"crossref","unstructured":"Smith HS, Passik SD (2008) Pain and chemical dependency. Oxford University Press, New York","DOI":"10.1093\/oso\/9780195300550.001.0001"},{"issue":"3","key":"4811_CR50","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","volume":"73","author":"MK Spearing","year":"1997","unstructured":"Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W (1997) Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 73(3):159\u2013171. https:\/\/doi.org\/10.1016\/S0165-1781(97)00123-6","journal-title":"Psychiatry Res"},{"issue":"10","key":"4811_CR51","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/j.pain.2012.06.024","volume":"153","author":"C Toth","year":"2012","unstructured":"Toth C, Mawani S, Brady S, Chan C, Liu C, Mehina E, Garven A, Bestard J, Korngut L (2012) An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain. Pain 153(10):2073\u20132082. https:\/\/doi.org\/10.1016\/j.pain.2012.06.024","journal-title":"Pain"},{"issue":"4","key":"4811_CR52","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","volume":"10","author":"DT Wade","year":"2004","unstructured":"Wade DT, Makela P, Robson P, House H, Bateman C (2004) Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult Scler (Houndmills, Basingstoke, England) 10(4):434\u2013441. https:\/\/doi.org\/10.1191\/1352458504ms1082oa","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"5","key":"4811_CR53","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1177\/1352458505070618","volume":"12","author":"DT Wade","year":"2006","unstructured":"Wade DT, Makela PM, House H, Bateman C, Robson P (2006) Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Mult Scler (Houndmills, Basingstoke, England) 12(5):639\u2013645. https:\/\/doi.org\/10.1177\/1352458505070618","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"2","key":"4811_CR54","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1213\/ANE.0b013e3181c76f70","volume":"110","author":"MA Ware","year":"2010","unstructured":"Ware MA, Fitzcharles MA, Joseph L, Shir Y (2010) The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analg 110(2):604\u2013610. https:\/\/doi.org\/10.1213\/ANE.0b013e3181c76f70","journal-title":"Anesth Analg"},{"issue":"12","key":"4811_CR55","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.jpain.2015.07.014","volume":"16","author":"MA Ware","year":"2015","unstructured":"Ware MA, Wang T, Shapiro S, Collet JP (2015) Cannabis for the management of pain: assessment of safety study (COMPASS). J Pain 16(12):1233\u20131242. https:\/\/doi.org\/10.1016\/j.jpain.2015.07.014","journal-title":"J Pain"},{"issue":"4","key":"4811_CR56","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/AJP.0b013e3180330dc5","volume":"23","author":"AD Wasan","year":"2007","unstructured":"Wasan AD, Butler SF, Budman SH, Benoit C, Fernandez K, Jamison RN (2007) Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain 23(4):307\u2013315. https:\/\/doi.org\/10.1097\/AJP.0b013e3180330dc5","journal-title":"Clin J Pain"},{"key":"4811_CR57","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jpainsymman.2006.05.010","volume":"32","author":"SA Wu","year":"2006","unstructured":"Wu SA, Compton P, Bolus R, Schieffer B, Pham Q, Baria A, Van Vort W, Davis F, Shekelle P, Naliboff BD (2006) The addiction behaviors checklist: validation of a new clinician-based measure of inappropriate opioid use in chronic pain. J Pain Symptom Manag 32:342\u2013351","journal-title":"J Pain Symptom Manag"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-017-4811-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4811-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4811-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T20:33:28Z","timestamp":1719693208000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-017-4811-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,17]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["4811"],"URL":"https:\/\/doi.org\/10.1007\/s00213-017-4811-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,17]]}}}